ASP Executive and Leadership Team

Vijay Kathir, the Chief Financial Officer, Latin America at ASP, manages the fiscal health and economic strategy for operations throughout the Latin American region. Overseeing capital allocation and financial reporting, Kathir ensures that the manufacturing of disinfectants and sterilization systems remains profitable within diverse market environments. This leadership role involves analyzing regional economic trends to inform investment decisions regarding the distribution of cleaning solutions. By optimizing financial workflows, Vijay Kathir supports the expansion of the company footprint in emerging medical markets. Kathir collaborates with global leadership to maintain budgetary discipline while funding innovation in sanitization technology. The Chief Financial Officer, Latin America monitors revenue streams and cost structures to ensure long-term financial stability. Through rigorous oversight of regional assets, the executive secures the necessary resources to maintain high-performance standards in the production and delivery of essential medical cleaning equipment.

Harvey Lipshits, the President at ASP, architects the operational framework and commercial strategy for the company. Overseeing the manufacturing of cleaning chemicals and sanitizers, Lipshits ensures that the organization delivers high-quality sterilization systems to healthcare providers. This leadership role involves driving product innovation and managing the lifecycle of equipment used for dispensing cleaning solutions. By fostering partnerships with medical institutions, Harvey Lipshits expands the market reach of the company. Lipshits coordinates with the executive team to align production capacity with the evolving needs of the medical industry. The President focuses on operational efficiency and the continuous improvement of sanitation protocols. Through the implementation of advanced manufacturing techniques, the executive ensures that the company remains a leader in the sterilization field. This leadership role supports the delivery of reliable, high-performance solutions that protect patients and staff in clinical environments.

Aisha M Barry, the President at ASP, directs the strategic initiatives and organizational growth for the business. Overseeing the development of advanced disinfectants and sterilization systems, Barry ensures that the company maintains a strong presence in the medical manufacturing landscape. This leadership role involves managing the integration of new technologies into the existing portfolio of cleaning solutions and dispensing equipment. By driving excellence in product design and service delivery, Aisha M Barry enhances the value proposition for healthcare clients. Barry collaborates with the board to define long-term objectives and market expansion strategies. The President focuses on optimizing internal processes to increase output and maintain high safety standards. Through the leadership of cross-functional departments, the executive ensures that the company meets the complex demands of the global medical sector. This role supports the mission of providing superior sterilization tools to improve clinical outcomes.

Nikhil Murgude, the Managing Director at ASP, directs the overarching strategic vision and operational execution for the organization. Overseeing the development of sterilization technologies, Murgude ensures that the manufacturing of cleaning chemicals and sanitizers meets rigorous international medical standards. This leadership role involves coordinating cross-functional teams to optimize the production of equipment and systems for dispensing cleaning solutions. By aligning internal resources with market demands, Nikhil Murgude drives sustainable growth across the medical manufacturing sector. Murgude maintains a focus on scaling production capabilities to support healthcare facilities globally. Through the implementation of efficient supply chain protocols, the Managing Director enhances the reliability of critical sanitation products. This executive leadership ensures that the company maintains a competitive edge in the medical device industry while upholding strict quality control measures across all regional operations.